ranitidine has been researched along with AIDS Seroconversion in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Smith, KC | 1 |
| Barditch-Crovo, PA; Gambertoglio, J; Hafner, R; Kornhauser, DM; Kuwahara, S; Lietman, PS; Nerhood, LJ; Petty, BG | 1 |
| Barbhaiya, RH; Dixon, RM; Graziano, FM; Knupp, CA | 1 |
2 trial(s) available for ranitidine and AIDS Seroconversion
| Article | Year |
|---|---|
The effect of increasing gastric pH upon the bioavailability of orally-administered foscarnet.
Topics: Administration, Oral; Antiviral Agents; Biological Availability; Chromatography, High Pressure Liquid; Cross-Over Studies; Double-Blind Method; Foscarnet; Gastric Acid; Histamine H2 Antagonists; HIV Infections; HIV Seropositivity; Humans; Hydrogen-Ion Concentration; Ranitidine | 1998 |
Pharmacokinetic-interaction study of didanosine and ranitidine in patients seropositive for human immunodeficiency virus.
Topics: Administration, Oral; Adult; Chromatography, High Pressure Liquid; Didanosine; Drug Interactions; Half-Life; HIV Seropositivity; Humans; Male; Random Allocation; Ranitidine | 1992 |
1 other study(ies) available for ranitidine and AIDS Seroconversion
| Article | Year |
|---|---|
Ranitidine useful in the management of psoriasis in a patient with acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Combined Modality Therapy; HIV Seropositivity; HIV-1; Humans; Male; Middle Aged; Psoriasis; Ranitidine; Ultraviolet Therapy | 1994 |